Free Trial
OTCMKTS:BFNH

BioForce Nanosciences 4/1/2024 Earnings Report

BioForce Nanosciences logo
$0.81 0.00 (0.00%)
As of 09/22/2025

BioForce Nanosciences EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioForce Nanosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioForce Nanosciences Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

BioForce Nanosciences' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules.

Conference Call Resources

BioForce Nanosciences Earnings Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
BioForce Nanosciences Holdings, Inc. (BFNH)
BioForce Nanosciences Holdings Inc (BFNH)
See More BioForce Nanosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioForce Nanosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioForce Nanosciences and other key companies, straight to your email.

About BioForce Nanosciences

BioForce Nanosciences (OTCMKTS:BFNH), Inc. develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning. In addition to equipment sales, BioForce Nanosciences offers contract research and custom development services, as well as licensing agreements for its intellectual property. Its technologies have been applied in areas such as drug delivery, tissue engineering, advanced filtration, composite materials and sensor development.

Serving academic institutions, government laboratories and corporate research centers, BioForce Nanosciences supports customers worldwide with training, application development and technical service. By combining instrumentation, service offerings and technology licensing, the company aims to accelerate the translation of nanomaterial innovations into practical solutions for life science, industrial and environmental applications.

View BioForce Nanosciences Profile

More Earnings Resources from MarketBeat